Positron-emitting resin microspheres as surrogates of 90Y SIR-Spheres:: a radiolabeling and stability study

被引:26
作者
Avila-Rodriguez, Miguel A. [1 ]
Selwyn, Reed G.
Hampel, Joseph A.
Thornadsen, Bruce R.
DeJesus, Onofre T.
Converse, Alexander K.
Nickles, Robert J.
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Phys, Madison, WI 53706 USA
[2] Univ Wisconsin, Waisman Ctr, Madison, WI 53706 USA
关键词
positron-emitting microspheres; SIR-Spheres; metallic radionuclides; PET imaging; yttrium-90; surrogates;
D O I
10.1016/j.nucmedbio.2007.04.003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Commercially available resin inicrospheres and SIR-Spheres were labeled with metallic positron emitters and evaluated as positron emission tomography (PET) imaging surrogates of Y-90 SIR-Spheres. Radiolabeling was performed using a batch method, and in vitro stability over 24 h was evaluated in saline at physiological pH at 37 degrees C. The activity per microsphere distribution, as evaluated by autoradiography, showed the activity per microsphere to be proportional to the square radius of the spheres, suggesting surface binding. The in vivo stability of radiolabeling was evaluated in rats by micro-PET imaging after the intravenous injection of labeled rnicrospheres. The different resin microspheres and radionuclides evaluated in this study all showed good radiolabeling efficiency and in vitro stability. However, only resins labeled with Y-86 and Zr-89 proved to have the in vivo stability required for clinical applications. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 17 条
[1]  
ANDREWS JC, 1994, J NUCL MED, V35, P1637
[2]  
Avila-Rodriguez MA, 2006, AIP CONF PROC, V854, P45, DOI 10.1063/1.2356397
[3]  
AVILARODRIGUEZ MA, 2007, IN PRESS APPL RADIAT
[4]  
BILLINGHURST MW, 1981, CHEM NUCL MED, P227
[5]  
Dancey JE, 2000, J NUCL MED, V41, P1673
[6]  
Gulec SA, 2006, J NUCL MED, V47, P1209
[7]   Radioembolization for hepatic metastases [J].
Herba, MJ ;
Thirlwell, MP .
SEMINARS IN ONCOLOGY, 2002, 29 (02) :152-159
[8]   Tumour-to-normal uptake ratio of Y-90 microspheres in hepatic cancer assessed with Tc-99(m) macroaggregated albumin [J].
Ho, S ;
Lau, WY ;
Leung, TWT ;
Chan, M ;
Chan, KW ;
Lee, WY ;
Johnson, PJ ;
Li, AKC .
BRITISH JOURNAL OF RADIOLOGY, 1997, 70 (836) :823-828
[9]   Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres [J].
Lau, WY ;
Ho, S ;
Leung, TWT ;
Chan, M ;
Ho, R ;
Johnson, PJ ;
Li, AKC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (03) :583-592
[10]   Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications [J].
Murthy, R ;
Nunez, R ;
Szklaruk, J ;
Erwin, W ;
Madoff, DC ;
Gupta, S ;
Ahrar, K ;
Wallace, MJ ;
Cohen, A ;
Coldwell, DM ;
Kennedy, AS ;
Hicks, ME .
RADIOGRAPHICS, 2005, 25 :S41-S56